| Identification | Back Directory | [Name]
Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- | [CAS]
2378837-56-8 | [Synonyms]
Butanamide, N-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-4,4-bis[14-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-5-oxo-2,9,12-trioxa-6-azatetradec-1-yl]-2,9-dioxo-6,13,16-trioxa-3,10-diazaoctadec-1-yl]-4-[[2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-6-quinolinyl]oxy]- | [Molecular Formula]
C78H119FN12O34 | [MOL File]
2378837-56-8.mol | [Molecular Weight]
1787.84 |
| Hazard Information | Back Directory | [Uses]
M-MoDE-A (2) is a bifunctional small molecule that mediates the degradation of extracellular proteins through the asialoglycoprotein receptor (ASGPR). | [References]
[1] Caianiello DF, et al. Bifunctional small molecules that mediate the degradation of extracellular proteins. Nat Chem Biol. 2021 Sep;17(9):947-953. DOI:10.1038/s41589-021-00851-1 |
|
|